-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Oramed Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Oramed Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$19.6M, a 509% decline year-over-year.
- Oramed Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $4.47M.
- Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $5.53M.
- Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.6M, a 59% decline from 2021.
- Oramed Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23M, a 99.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)